Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
CEO: |
Riad Mishlawi |
Non-Executive Director: |
Ali Al-Husry |
Executive Chairman: |
Said Darwazah |
Senior Independent Director: |
Victoria Hull |
Independent Non-Executive Director: |
Douglas Hurt, John J. Castellani, Laura Balan Balan, Mary (Nina) Henderson, Cynthia Schwalm, Deneen Vojta |
Executive Vice Chairman: |
Mazen Darwazah |
Address: |
1 New Burlington Place, London,United Kingdom |
Phone: |
+44 (0)20 7399 2760 |
Fax: |
+44 (0)20 7399 2761 |
Website: |
http://www.hikma.com |
Email: |
|